MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 6.694
EU - Europa 1.499
AS - Asia 985
SA - Sud America 9
AF - Africa 2
OC - Oceania 2
Totale 9.191
Nazione #
US - Stati Uniti d'America 6.689
CN - Cina 622
UA - Ucraina 497
TR - Turchia 334
DE - Germania 241
GB - Regno Unito 219
PL - Polonia 146
IT - Italia 110
SE - Svezia 107
FI - Finlandia 104
BE - Belgio 28
FR - Francia 27
VN - Vietnam 10
IR - Iran 9
IN - India 7
NL - Olanda 6
CL - Cile 5
RO - Romania 4
BR - Brasile 3
CA - Canada 3
DK - Danimarca 2
ES - Italia 2
MX - Messico 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AT - Austria 1
AU - Australia 1
EE - Estonia 1
IS - Islanda 1
KG - Kirghizistan 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 9.191
Città #
Woodbridge 897
Fairfield 876
Houston 578
Jacksonville 562
Ashburn 511
Ann Arbor 502
Chandler 433
Seattle 331
Wilmington 309
Cambridge 252
Izmir 174
Nanjing 169
Warsaw 146
Dearborn 127
Beijing 108
Princeton 107
San Diego 103
Boardman 73
Addison 68
Shenyang 48
Nanchang 43
Milan 42
Hebei 35
Ferrara 33
New York 33
Brussels 28
Jiaxing 28
Shanghai 28
Washington 26
Jinan 23
San Mateo 23
Tianjin 23
Auburn Hills 21
Bremen 19
Changsha 18
Kunming 18
London 16
Mountain View 16
Zhengzhou 15
Hefei 13
Falls Church 12
Norwalk 12
Ningbo 11
Dong Ket 10
Los Angeles 10
Des Moines 9
Indiana 9
Redwood City 9
Guangzhou 8
Orange 8
Ardabil 7
Philadelphia 7
Augusta 6
Verona 6
Lanzhou 5
Leawood 5
Haikou 4
Helsinki 4
Hounslow 3
Redmond 3
Tappahannock 3
Bologna 2
Changchun 2
Chengdu 2
Florence 2
Fuzhou 2
Kilburn 2
Madrid 2
New Bedfont 2
Orpington 2
Phoenix 2
Qingdao 2
San Francisco 2
Southwark 2
São Paulo 2
Toronto 2
Walnut 2
Yellow Springs 2
Abbeville 1
Acton 1
Auckland 1
Baotou 1
Bari 1
Beirã 1
Bishkek 1
Bolton 1
Boulder 1
Cape Town 1
Caruaru 1
Chicago 1
Chiswick 1
Clearwater 1
Copenhagen 1
Delhi 1
Distrito Federal 1
Düsseldorf 1
Edinburgh 1
Ercolano 1
Frankfurt am Main 1
Garza García 1
Totale 7.082
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 253
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 146
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 134
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 131
Vinyl ester-based cyclic peptide proteasome inhibitors 126
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 126
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 121
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 120
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 119
Arecoline tripeptide inhibitors of proteasome 119
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 118
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 116
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 112
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 110
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 110
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 110
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 109
null 107
null 107
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 106
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 106
Structure-activity relationships of cyclic and linear peptide T analogues. 106
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 106
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 105
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 104
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 103
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 102
Synthesis and biological activity of carboxyl terminally extended dermorphins. 102
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 102
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 101
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 101
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 100
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 100
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 100
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 99
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. 99
A Bioactive Fullerene Peptide 99
A 500 MHz study of peptide T in a DMSO solution. 99
Conformational analysis of peptide T and of its C‐pentapeptide fragment 98
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 98
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 98
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 97
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 97
null 96
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 96
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin. 96
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 96
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 94
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 93
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 93
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides. 93
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 92
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 90
null 90
null 90
null 89
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 87
null 87
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 86
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 86
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 84
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 84
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 83
Synthesis and structure activity relationships of delthorphine analogues 80
null 79
New cyclic peptide proteasome inhibitors 78
Opioid peptides. Partially modified retro-inverso dermorphin analogues 77
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 76
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 75
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 73
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 73
null 72
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 71
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 70
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid. 67
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 66
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 65
Anodic mineralization of pentachlorophenol in alkaline media 64
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives. 64
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure. 64
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 64
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides. 63
null 62
Synthesis and activity of new linear and cyclic peptide T derivatives. 62
Synthesis and biological activity of chelator-peptide T conjugates 61
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 61
Dehydro-dermorphins. II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides. 61
Conformational properties of deltorphin: new features of the delta-opioid receptors 60
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 60
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 60
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 59
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage. 59
Dehydro-dermorphins. I. Influence of the stereo-orientation of aromatic groups in dermorphin-(1-5)-peptides to opioid activity. 58
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 57
Peptide-based molecules for the production of positive charged liposomes and micelles 56
Synthesis and antiaggregatory activity of antiflammin related peptides. 56
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin. 54
Structure-activity relationships of peptide T-related pentapeptides. 54
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 49
null 46
Totale 9.003
Categoria #
all - tutte 31.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 411
Totale 31.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019998 0 0 0 0 0 0 0 0 0 235 281 482
2019/20202.315 377 72 76 319 163 301 291 241 179 202 55 39
2020/20211.334 122 113 59 175 46 144 53 156 27 181 189 69
2021/20221.267 44 91 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024427 47 76 50 13 62 131 17 28 3 0 0 0
Totale 9.296